Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript - Thomson StreetEvents

Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript

Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript - Thomson StreetEvents
Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript
Published Sep 09, 2025
7 pages (4225 words) — Published Sep 09, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROIV.OQ presentation 9-Sep-25 6:00pm GMT

  
Brief Excerpt:

...Okay. Welcome everybody. We'll kick things off. I'm Douglas, senior analyst at HC Wainwright. We are thrilled to have with us (technical difficulty) up next represented by the company's CFO, Richard Pulik. I've known Richard for almost a decade. There was a little break in there from when I knew you at Nevada. So a lot going on at Roivant and maybe we'll start with giving you Immunovant business because I think you recently had some additional data in Graves, and you recently showed an update in terms of remission and durability of the effect which I think enhanced investors' confidence. I guess maybe as a starting point just what were some of your takeaways from that incremental data and you know in the past, Immunovant was focused on thyroid eye disease and then the company sort of shifted to graves because they thought it was a better opportunity. What makes you as a company sort of think that Graves is a better opportunity even though others right, like Argenx is still pursuing TED....

  
Report Type:

Transcript

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
6:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary – 2025-09-23 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 23-Sep-25 6:00pm GMT

Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Transcript – 2025-09-23 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 23-Sep-25 6:00pm GMT

Roivant Sciences Ltd Brepocitinib in DM: VALOR Phase 3 Study Results Summary – 2025-09-17 – US$ 54.00 – Edited Brief of ROIV.OQ conference call or presentation 17-Sep-25 12:00pm GMT

Roivant Sciences Ltd Brepocitinib in DM: VALOR Phase 3 Study Results Transcript – 2025-09-17 – US$ 54.00 – Edited Transcript of ROIV.OQ conference call or presentation 17-Sep-25 12:00pm GMT

Roivant Sciences Ltd at HC Wainwright Global Investment Conference Summary – 2025-09-09 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 9-Sep-25 6:00pm GMT

Roivant Sciences Ltd at Morgan Stanley Global Healthcare Conference Summary – 2025-09-08 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 8-Sep-25 9:35pm GMT

Roivant Sciences Ltd at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-08 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 8-Sep-25 9:35pm GMT

Roivant Sciences Ltd at Wells Fargo Healthcare Conference Summary – 2025-09-04 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 4-Sep-25 7:00pm GMT

Roivant Sciences Ltd at Wells Fargo Healthcare Conference Transcript – 2025-09-04 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 4-Sep-25 7:00pm GMT

Roivant Sciences Ltd at Cantor Global Healthcare Conference Summary – 2025-09-03 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 3-Sep-25 12:35pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript" Sep 09, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-HC-Wainwright-Global-Investment-Conference-T16494310>
  
APA:
Thomson StreetEvents. (2025). Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript Sep 09, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-HC-Wainwright-Global-Investment-Conference-T16494310>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.